HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tina C Wan Selected Research

CP-532,903

1/2019Ability of CP-532,903 to protect mouse hearts from ischemia/reperfusion injury is dependent on expression of A3 adenosine receptors in cardiomyoyctes.
9/2008Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils.
1/2008The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tina C Wan Research Topics

Disease

6Reperfusion Injury
01/2019 - 08/2003
6Infarction (Infarctions)
11/2010 - 08/2003
5Myocardial Infarction
01/2022 - 03/2004
5Ischemia
10/2011 - 03/2004
5Myocardial Ischemia (Ischemic Heart Diseases)
08/2010 - 08/2003
3Inflammation (Inflammations)
09/2011 - 09/2008
3Coronary Occlusion
08/2010 - 08/2003
1Fibrosis (Cirrhosis)
12/2020
1Neoplasm Metastasis (Metastasis)
02/2017
1Lung Neoplasms (Lung Cancer)
02/2017
1Hypothermia
01/2017
1Body Weight (Weight, Body)
12/2015
1Chronic Disease (Chronic Diseases)
12/2015
1Hypertension (High Blood Pressure)
12/2015
1Peritonitis
08/2010
1Hypoxia (Hypoxemia)
12/2009
1Heart Failure
03/2004

Drug/Important Bio-Agent (IBA)

7Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2019 - 08/2003
5Adenosine (Adenocard)FDA LinkGeneric
01/2017 - 12/2006
3CP-532,903IBA
01/2019 - 01/2008
3N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
08/2010 - 08/2003
2Adenosine Triphosphate (ATP)IBA
01/2008 - 08/2003
2triphenyltetrazoliumIBA
03/2004 - 08/2003
1AcetyltransferasesIBA
01/2022
1Cre recombinaseIBA
12/2020
1TamoxifenFDA LinkGeneric
12/2020
1honokiolIBA
02/2017
1Adenosine Monophosphate (AMP)IBA
01/2017
1N(6)-cyclopentyladenosineIBA
01/2017
1N(6)-cyclohexyladenosineIBA
01/2017
1Glucose (Dextrose)FDA LinkGeneric
12/2015
1LipopolysaccharidesIBA
12/2015
1CytokinesIBA
12/2015
1NucleosidesIBA
10/2011
1PAMAM StarburstIBA
10/2011
1Troponin IIBA
11/2010
1BAY 60-6583IBA
11/2010
1KATP ChannelsIBA
01/2008
1PotassiumIBA
01/2008
1Phenol (Carbolic Acid)FDA Link
12/2006
1pyridineIBA
12/2006
1ZM 241385 (ZM241385)IBA
12/2006
12,3- diethyl- 4,5- dipropyl- 6- phenylpyridine- 3- thiocarboxylate- 5- carboxylateIBA
12/2006
1PropionatesIBA
03/2004
1Barbital (Barbitone)IBA
03/2004
1BG 9928IBA
03/2004
1DiureticsIBA
03/2004
1Purinergic P1 Receptor AntagonistsIBA
03/2004
11,3- dipropyl- 8- (2- (5,6- epoxy)norbornyl)xanthineIBA
03/2004
1XanthineIBA
03/2004
1Saline SolutionIBA
08/2003
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
08/2003
1Glyburide (Glibenclamide)FDA LinkGeneric
08/2003
1Potassium Channels (Potassium Channel)IBA
08/2003

Therapy/Procedure

1Microspheres (Microsphere)
08/2003